Skip to content
  • Home
  • About Us
  • Longevity Platform
  • Bio101
    • BIO101 in Sarcopenia
    • BIO101 in Obesity
  • Biophytis Biopharmaceutical
  • Other Projects
  • Resources
    • Posters & Publications
    • Scientific Press Releases
  • Recruitment
  • Investors
    • Stock Information
    • Corporate Presentation
    • Letter to shareholders
    • Press Releases
    • General Meetings
    • AMF Regulated Information
    • SEC Filings
    • Convertible bonds
    • Pre-financed vouchers (PFW)
    • Obligations Hexagon
    • Obligations Hexagon
    • Contact for Investors
  • Contact

    TNC FlipBook Classic items

    2021-10_29_Biophytis_Annonce_les_Resultats_Corriges_pour_les_Periodes_Anterieures_et_au_30_Juin_2021

    By adminNovember 1, 2025

    2021-10-07_Biophytis_to_Restate_Previously_Issued_Financial_Statements_EN

    By adminNovember 1, 2025

    2021-10-20_Biophytis_to_Report_Restated_Financial_Results_for_Previous_Periods_and_as_of_June_30_2021

    By adminNovember 1, 2025

    Biophytis obtient une nouvelle structure de prêt de 10 M€ avec Kreos Capital

    By adminNovember 1, 2025

    Biophytis announces US centers to restart recruitment for the COVA phase 2-3 study with Sarconeos (BIO101) in COVID-19

    By adminNovember 1, 2025

    Biophytis annonce la reprise du recrutement dans les centres aux Etats-Unis pour l’étude COVA de phase 2-3 avec Sarconeos (BIO101) dans la COVID-19

    By adminNovember 1, 2025

    Biophytis announces the drawing of the last tranche of ORNANE under the 2020 Atlas Contract for €3 million

    By adminNovember 1, 2025

    2021-12-15_SARA_CP_EOP2_MEETING_FDA_FR

    By adminNovember 1, 2025

    2021-12-15_SARA_PR_EOP2_MEETING_FDA_EN

    By adminNovember 1, 2025

    Biophytis obtains a new 10M€ loan structure with Kreos Capital

    By adminNovember 1, 2025
    ←1
    234
    …56789…
    101112131415161718192021222324252627282930313233
    34→
    X
    Addresses
    Addresses

    BIOPHYTIS France
    Silver Innov’
    54 rue Molière
    94200 Ivry-Sur-Seine
    FRANCE

    Addresses

    BIOPHYTIS USA
    c/o NGIN
    210 Broadway, Suite #201
    Cambridge, MA 02139
    USA

    Addresses

    BIOPHYTIS Brazil
    CIETEC
    Av. Prof. Lineu Prestes
    2242 Cidade Universitária USP
    05508-000 São Paulo
    BRASIL

    Contact
    contact@biophytis.com +33 1 76 28 40 83
    Investors

    investors@biophytis.com

    © Biophytis 2025.

    All Rights Reserved.

    Legal information
    Webdesign by Ex Calibra
    Go to Top
    • Home
    • About Us
    • Longevity Platform
    • Bio101
      • BIO101 in Sarcopenia
      • BIO101 in Obesity
    • Biophytis Biopharmaceutical
    • Other Projects
    • Resources
      • Posters & Publications
      • Scientific Press Releases
    • Recruitment
    • Investors
      • Stock Information
      • Corporate Presentation
      • Letter to shareholders
      • Press Releases
      • General Meetings
      • AMF Regulated Information
      • SEC Filings
      • Convertible bonds
      • Pre-financed vouchers (PFW)
      • Obligations Hexagon
      • Obligations Hexagon
      • Contact for Investors
    • Contact